PUBLISHER: The Business Research Company | PRODUCT CODE: 1713536
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713536
Biliary catheters are small, flexible tubes inserted into the common bile duct to facilitate the drainage of bile from the gallbladder and liver. These catheters can either channel bile internally into the intestines or externally into a collection bag outside the body. The insertion is typically done percutaneously, through the skin, and the catheter may be linked to an external drainage bag.
The several types of biliary catheters, including multi-purpose drainage catheters, multi-purpose drainage sump catheters, biliary drainage catheters, nephrostomy catheters, and ureteral stents, among others. Multi-purpose drainage catheters are designed for a range of fluid drainage needs from different body areas. They are used in procedures such as thrombectomy, drainage, occlusion, infusion, aspiration, dialysis, diagnostics, monitoring, stent delivery, and dilatation. These catheters are utilized by clinics, hospitals, and other healthcare facilities.
The biliary catheters market research report is one of a series of new reports from The Business Research Company that provides biliary catheters market statistics, including biliary catheters industry global market size, regional shares, competitors with a biliary catheters market share, detailed biliary catheters market segments, market trends and opportunities, and any further data you may need to thrive in the biliary catheters industry. This biliary catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biliary catheters market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.75 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rise in incidence of biliary tract diseases, increasing minimally invasive procedure, rise in aging population, growth in liver transplants, and rise in healthcare spending.
The biliary catheters market size is expected to see strong growth in the next few years. It will grow to $5.38 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing healthcare expenditure, increasing prevalence of lifestyle-related disease, rising number of endoscopic procedures, increasing frequency of biliary illnesses, and increasing emphasis on diagnostic procedures. Major trends in the forecast period include technological advancements, advanced imaging techniques, biodegradable catheter, 3D printing, and smart technologies.
The increasing incidence of liver disease is expected to drive growth in the biliary catheters market. The rise in liver diseases is influenced by factors such as the growing prevalence of chronic hepatitis infections, alcohol abuse, and non-alcoholic fatty liver disease (NAFLD). Biliary catheters play a crucial role in managing liver disease complications by ensuring proper bile drainage, which helps alleviate symptoms, prevent infections, and maintain liver function. For example, in April 2024, the Office for Health Improvement & Disparities, a UK-based government organization, reported that the premature mortality rate due to alcoholic liver disease increased to 11.6 per 100,000 population in 2022, up from 11.5 in 2021. As a result, the rise in liver disease cases is driving the growth of the biliary catheters market.
Major companies in the biliary catheter market are developing innovative products with advanced coating technologies, such as TrueGlide hydrophilic coating, to improve catheter performance and usability. TrueGlide hydrophilic coating reduces friction and ensures smooth catheter insertion during medical procedures. For example, in June 2024, B. Braun Interventional Systems Inc., a US-based medical device company, launched its ACCEL all-purpose and biliary drainage catheters featuring TrueGlide hydrophilic coating. These catheters are designed to enhance patient comfort and clinical outcomes, with large oval holes for optimal fluid drainage and a hydrophilic coating for smooth insertion. This new product expands B. Braun's percutaneous drainage portfolio, offering a comprehensive solution for fluid management and addressing various clinical needs.
In January 2024, Olympus Corporation, a medical technology company based in Japan, acquired Taewoong Medical for an undisclosed amount. This acquisition is intended to bolster Olympus's portfolio in the gastrointestinal sector by broadening its range of endoscopic and interventional products. The deal could influence the market by expanding Olympus's product offerings and potentially fostering innovation in biliary catheter technologies. Taewoong Medical, a medical device manufacturer based in South Korea, produces a variety of medical equipment, including biliary stents, urology stents, RFA treatment devices, and related accessories.
Major companies operating in the biliary catheters market are Abbott Laboratories, Medtronic plc, Fujifilm Holdings Corporation, Stryker Corporation, Boston Scientific Corporation, Medline Industries Inc., B. Braun Melsungen AG, Olympus Corporation, Edwards Lifesciences Corporation, Nipro Medical Corporation, Smiths Medical, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., C. R. Bard Inc., ASAHI INTECC CO. LTD., AngioDynamics Inc., Galt Medical Corp., EndoFlex GmbH, Taewoong Medical Co. Ltd., M.I. Tech Co. Ltd., Marflow AG, Navilyst Medical Inc.
North America was the largest region in the biliary catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biliary catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biliary catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biliary catheters market consists of sales of foley catheter, Hickman catheter, peritoneal dialysis catheter and suprapubic catheter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biliary Catheters Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biliary catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biliary catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biliary catheters market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.